Bookmark
Forward
ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis.
Hao Liu, Amer Zureikat
Annals of surgical oncology 2020 Oct
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Hao Liu, Amer Zureikat.
ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis.
Annals of surgical oncology.
2020 Oct;27(10):3961-3962
Mesh Tags
CA-19-9 Antigen
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms
Survival Rate
Substances
CA-19-9 Antigen
PMID: 32372314
View Full Text